Heart Diseases |
Cardiac Arrest; Cardiac Diseases; Endocarditis; Heart Disease; Heart Disease and the Mind-Body Constitution; Heart Disease, Congenital; Heart Diseases (General); Heart Diseases--Prevention; Heart Infection, Endocarditis |
Clinical Trial: Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training
This study is currently recruiting patients.
Purpose
To determine the long-term safety and effectiveness of exercise training for congestive heart failure patients.
| Condition | Treatment or Intervention |
|---|---|
| Cardiovascular Diseases Heart Diseases Heart Failure | Behavior: exercise |
MedlinePlus related topics: Cardiomyopathy; Heart Diseases; Heart Diseases--Prevention; Vascular Diseases
Study Type: Interventional
Study Design: Prevention
Study start: September 2002; Expected completion: July 2006
BACKGROUND: Congestive heart failure afflicts approximately five million Americans and is the number one cause of hospital admission in persons over the age of 65. Although exercise training improves several correlates of survival in patients with heart failure (e.g., peak VO2, heart rate variability, and plasma norepinephrine levels) it is not known whether exercise training reduces mortality in subjects with congestive heart failure.
DESIGN NARRATIVE: A multicenter randomized clinical trial to determine if exercise training reduces mortality and hospitalizations in persons with moderate to severe heart failure. The secondary objective is to evaluate to what extent an exercise program designed for heart failure patients improves quality of life and functioning, is economically advantageous, and avoids medical complications.
Heart failure afflicts approximately five million Americans and is the number one cause of hospital admission in persons over the age of 65. Although exercise training seems to improve health status as measured through several physiologic indicators, it is not known whether exercise training also reduces mortality and hospitalizations in persons with heart failure.
The trial plans to randomly assign 3,000 patients with moderate to severe heart failure to either standard medical therapy and education alone, or standard medical therapy and education plus a supervised exercise training program. The exercise training will include 36 supervised clinic-based training sessions followed by home-based exercise and periodic supervised sessions for reinforcement. Patients randomized to the training arm of the study will train by either treadmill or stationary bicycle. A treadmill or exercise bicycle will be provided to each training patient.
The trial will take place over 5 years, with an initial 6 months for planning, training, and implementation. Recruitment began in the Spring of 2003.
Eligibility
Genders Eligible for Study: Both
Criteria
Location and Contact Information
Alabama
University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States; Recruiting
Vera A. Bittner, Study Chair
California
University of California Los Angeles, Los Angeles, California, 90095, United States; Recruiting
Gregg C. Fonarow, Study Chair
University of California at San Diego Medical Center, San Diego, California, 92103, United States; Recruiting
Denise Hermann, Principal Investigator
Colorado
University of Colorado Health Sciences Center, Denver, Colorado, 80262, United States; Recruiting
Eugene Wolfel, Study Chair
Connecticut
Hartford Hospital, Hartford, Connecticut, 06102, United States; Recruiting
Paul Thompson, Principal Investigator
District of Columbia
VA Medical Center, Washington, District of Columbia, 20422, United States; Recruiting
Peter Kokkinos, Principal Investigator
Florida
Shands Hospital, Gainesville, Florida, 32610, United States; Recruiting
James Hill, Principal Investigator
Mayo Clinic, Jacksonville, Florida, 32216, United States; Recruiting
Gerald Fletcher, Principal Investigator
Georgia
Emory University Hospital, Atlanta, Georgia, 30322, United States; Recruiting
Andrew L. Smith, Study Chair
Cardiovascular Associates of Augusta, Augusta, Georgia, 30901, United States; Recruiting
A. Bleakley Chandler, Principal Investigator
Morehouse School of Medicine, Atlanta, Georgia, 30310, United States; Recruiting
Elizabeth Ofili, Principal Investigator
Illinois
Northwestern University Medical Center, Chicago, Illinois, 60611, United States; Recruiting
Mihai Gheorghiade, Principal Investigator
Iowa
University of Iowa Hospital and Clinics, Iowa City, Iowa, 52242-1081, United States; Recruiting
Ron Oren, Principal Investigator
Kentucky
University of Louisville, Louisville, Kentucky, 40292, United States; Recruiting
Ann Swank, Principal Investigator
Louisiana
Cardiac Centers of Louisiana, LLC, Shreveport, Louisiana, 71135, United States; Recruiting
Jalal Ghali, Principal Investigator
Ochsner Clinic Foundation, New Orleans, Louisiana, 70121, United States; Recruiting
Mandeep Mehra, Principal Investigator
Massachusetts
Boston University Medical Center, Boston, Massachusetts, 02118, United States; Recruiting
Daniel E. Forman, Study Chair
Michigan
Henry Ford Hospital, Detroit, Michigan, 48202, United States; Recruiting
Steven Keteyian, Study Chair
Saint John Hospital and Medical Center, Detroit, Michigan, 48236, United States; Recruiting
Julius Gardin, Principal Investigator
Beaumont Health Center, Royal Oak, Michigan, 48073, United States; Recruiting
Peter McCullough, Principal Investigator
Minnesota
University of Minnesota, Minneapolis, Minnesota, 55455, United States; Recruiting
Monica Colvin-Adams, Principal Investigator
Missouri
Washington University School of Medicine, St. Louis, Missouri, 63110, United States; Recruiting
Gregory A. Ewald, Study Chair
Cardiovascular Consultants, Kansas City, Missouri, 64111, United States; Recruiting
Tracy Stevens, Principal Investigator
New Jersey
University of Medicine & Dentistry of New Jersey, New Brunswick, New Jersey, 08901, United States; Recruiting
John Kostis, Principal Investigator
New York
North Suffolk Cardiology Associates, PC, E. Setauket, New York, 11733, United States; Recruiting
John Reitano, Principal Investigator
Columbia University Heart Failure Center, Bronxville, New York, 10708, United States; Recruiting
Susan Restaino, Principal Investigator
North Carolina
Wake Forest University School of Medicine, Winston Salem, North Carolina, 27157, United States; Recruiting
Dalane W. Kitzman, Study Chair
University of North Carolina School of Medicine, Chapel Hill, North Carolina, 27599-7075, United States; Recruiting
Kirkwood Adams, Principal Investigator
Duke Medical Center, Durham, North Carolina, 27710, United States; Recruiting
William Kraus, Principal Investigator
Ohio
Davis Heart and Lung Research Institute, Columbus, Ohio, 43210, United States; Recruiting
William T. Abraham, Study Chair
University Hospitals of Cleveland, Cleveland, Ohio, 44106, United States; Recruiting
Ileana Pina, Study Chair
Cleveland Clinic Foundatin, Cleveland, Ohio, 44195, United States; Recruiting
Gordon Blackburn, Principal Investigator
University of Cincinnati, Cincinnati, Ohio, 45267-0542, United States; Recruiting
Lynne Wagoner, Principal Investigator
Medical College of Ohio, Toledo, Ohio, 43614-2598, United States; Recruiting
Dalynn Badenhop, Principal Investigator
Oklahoma
Tulsa, Oklahoma, 74136, United States; Recruiting
J. Frederick McNeer, Principal Investigator
Oklahoma University Health Science Center, Oklahoma City, Oklahoma, 73104, United States; Recruiting
Udho Thadani, Principal Investigator
Oregon
Oregon Health & Sciences University, Portland, Oregon, 97239, United States; Recruiting
Ray E. Hershberger, Study Chair
Pennsylvania
University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States; Recruiting
Andrew Kao, Principal Investigator
South Carolina
Medical University of South Carolina, Charleston, South Carolina, 29403, United States; Recruiting
MIchael Zile, Principal Investigator
Texas
Medical City Hospital, Dallas, Texas, 75230, United States; Recruiting
Eric Eichhorn, Principal Investigator
Utah
LDS Hospital, Salt Lake City, Utah, 84143, United States; Recruiting
Frank Yanowitz, Principal Investigator
Wisconsin
University of Wisconsin Madison, Madison, Wisconsin, 53792, United States; Recruiting
Maryl Johnson, Principal Investigator
Canada, Alberta
University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Recruiting
Debra Isaac, Principal Investigator
Canada, Manitoba
University of Manitoba Health Sciences Center, Winnipeg, Manitoba, R2H2A6, Canada; Recruiting
Eduardo Azevedo, Principal Investigator
Canada, Nova Scotia
Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia, B3K6A3, Canada; Recruiting
Jonathan Howlett, Principal Investigator
Canada, Ontario
London Health Sciences Center, London, Ontario, N6A 4G5, Canada; Recruiting
Malcolm Arnold, Principal Investigator
Hamilton General Hospital, Hamilton, Ontario, L8L 2X2, Canada; Recruiting
Robert McKelvie, Principal Investigator
Saint Michaels Hospital, Toronto, Ontario, M5B 1W8, Canada; Recruiting
Gordon Moe, Principal Investigator
University Health Network, Toronto, Ontario, M5T 258, Canada; Recruiting
Kenneth Melvin, Principal Investigator
Canada, Quebec
Laval Hospital, Sainte-Foy, Quebec, G1V 4G5, Canada; Recruiting
Marie-Helene LeBlanc, Principal Investigator
William Abraham, Davis Heart and Lung Research Institute
Vera Bittner, University of Alabama, Birmingham
Gregory Ewald, Washington University School of Medicine
Gregg Fonarow, University of California, Los Angeles
Daniel Forman, Boston University Medical Center
Ray Hershberger, Oregon Health and Science University
Steven Keteyian, Henry Ford Hospital
Dalane Kitzman, Wake Forest University
Christopher O'Connor, Duke University
Ileana Pina, University Hospitals of Cleveland
Kevin Schulman, Duke University
Andrew Smith, Emory University Hospital
Eugene Wolfel, University of Colorado
More Information
Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training
Record last reviewed: March 2005
Last Updated: April 1, 2005
Record first received: October 3, 2002
ClinicalTrials.gov Identifier: NCT00047437
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


